Trademark Search in Canada

LYTENAVA

View On IC.GC.CA

REGISTERED

Last Applicant/ Owned by

Outlook Therapeutics, Inc.

7 Clarke DriveCranbury NJ 08512

Serial Number

2062151 filed on 1^st Oct 2020

Registration Number

TMA1132404 registered on 22^nd Jun 2022

Registration expiry Date

1^st Oct 2030

Correspondent Address

SMART & BIGGAR LP

Scotia Plaza, 40 King Street West40th FloorToronto

ONTARIO

M5H3Y2

LYTENAVA

Trademark usage description

injectable pharmaceutical preparations for the treatment of retinal disease; pharmaceuticals, namely, ophthalmic drugs for the treatment of retinal di Read More

Classification Information

Class [005]
Injectable pharmaceutical preparations for the treatment of retinal disease; pharmaceuticals, namely, ophthalmic drugs for the treatment of retinal disease.

Classification kind code

Mark Details

Serial Number

2062151

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 27 on 7^th Mar 2022	Approval Notice Sent
Submitted for opposition 26 on 7^th Mar 2022	Approved
Submitted for opposition 22 on 1^st Mar 2022	Search Recorded
Submitted for opposition 256 on 6^th Sept 2021	Notification of Possible Opposition Sent
Submitted for opposition 48 on 3^rd Mar 2021	Agent Changed
Submitted for opposition 257 on 5^th Nov 2020	Designation Notification - Madrid Protocol
Submitted for opposition 31 on 4^th Nov 2020	Formalized
Submitted for opposition 1 on 4^th Nov 2020	Created
Submitted for opposition 30 on 1^st Oct 2020	Filed
Submitted for opposition 228 on 1^st Oct 2020	International Registration

LYTENAVA

Classification Information

Class [005]Injectable pharmaceutical preparations for the treatment of retinal disease; pharmaceuticals, namely, ophthalmic drugs for the treatment of retinal disease.

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [005]
Injectable pharmaceutical preparations for the treatment of retinal disease; pharmaceuticals, namely, ophthalmic drugs for the treatment of retinal disease.